HYBT Stock Price, Chart, Stats & News

Heyu Biological Technology Corporation
Save
Heyu Biological Technology Corporation (HYBT) does not currently pay a dividend.
361.36M
Market cap
ā
Current P/E
ā
Forward P/E
HYBT chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Devices
Industry
Heyu Biological Technology Corporation, alongside its subsidiaries, focuses on the research, development, and production of healthcare equipment. A key area of its present work involves developing the Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical device intended for cancer treatment. This innovative equipment is designed to induce cold nuclear fusion via cosmic ray muons within a contained environment to combat the disease.
Similar securities
Based on sector and market capitalization
Report issue











